Cargando…

Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use

BACKGROUND: Dementia networks in Germany constitute a specialised setting for integrated dementia care and have shown benefits on relevant outcomes, including those of drug treatment. National guidelines recommend treatment with acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wübbeler, Markus, Wucherer, Diana, Hertel, Johannes, Michalowsky, Bernhard, Heinrich, Steffen, Meyer, Saskia, Schaefer-Walkmann, Susanne, Hoffmann, Wolfgang, Thyrian, Jochen René
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460966/ https://www.ncbi.nlm.nih.gov/pubmed/25998147 http://dx.doi.org/10.1186/s12913-015-0855-7

Ejemplares similares

Nonpharmacological therapies and provision of aids in outpatient dementia networks in Germany: utilization rates and associated factors
por: Wübbeler, Markus, et al.
Publicado: (2015)

Quality of life in persons with dementia using regional dementia care network services in Germany: a one-year follow-up study
por: Gräske, Johannes, et al.
Publicado: (2018)

Potentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia
por: Wucherer, Diana, et al.
Publicado: (2016)

Rates of formal diagnosis of dementia in primary care: The effect of screening
por: Eichler, Tilly, et al.
Publicado: (2015)

Subjective memory impairment: No suitable criteria for case-finding of dementia in primary care
por: Eichler, Tilly, et al.
Publicado: (2015)

Systematic, early identification of dementia and dementia care management are highly appreciated by general physicians in primary care – results within a cluster-randomized-controlled trial (DelpHi)
por: Thyrian, Jochen René, et al.
Publicado: (2016)

Associations Between Low-Value Medication in Dementia and Healthcare Costs
por: Platen, Moritz, et al.
Publicado: (2022)

Prevalence of Low-Value Care and Its Associations with Patient-Centered Outcomes in Dementia
por: Platen, Moritz, et al.
Publicado: (2021)

Dementia care management: going new ways in ambulant dementia care within a GP-based randomized controlled intervention trial
por: Eichler, Tilly, et al.
Publicado: (2014)

Identifying Unmet Needs of Family Dementia Caregivers: Results of the Baseline Assessment of a Cluster-Randomized Controlled Intervention Trial
por: Zwingmann, Ina, et al.
Publicado: (2019)

Why do family dementia caregivers reject caregiver support services? Analyzing types of rejection and associated health-impairments in a cluster-randomized controlled intervention trial
por: Zwingmann, Ina, et al.
Publicado: (2020)

Drug-related problems in community-dwelling primary care patients screened positive for dementia
por: Wucherer, D., et al.
Publicado: (2017)

Tasks and Activities of an Effective Collaborative Dementia Care Management Program in German Primary Care
por: Mühlichen, Franka, et al.
Publicado: (2022)

The use of antidementia therapy in non-dementia cognitive disorders associated with COVID-19
por: Liubov, P., et al.
Publicado: (2023)

Regionale Gesundheitsnetzwerke in Deutschland: Charakteristik und Finanzierung am Beispiel regionaler Demenznetzwerke
por: Michalowsky, Bernhard, et al.
Publicado: (2022)

Medication management for people with dementia in primary care: description of implementation in the DelpHi study
por: Fiß, Thomas, et al.
Publicado: (2013)

Cost of diagnosing dementia in a German memory clinic
por: Michalowsky, Bernhard, et al.
Publicado: (2017)

Types of leisure time physical activities (LTPA) of community-dwelling persons who have been screened positive for dementia
por: Müller, Britta, et al.
Publicado: (2021)

Dementia and migration: culturally sensitive healthcare services and projects in Germany: A scoping review
por: Monsees, Jessica, et al.
Publicado: (2022)

The impact of Medicare prescription drug coverage on the use of antidementia drugs
por: Fowler, Nicole R, et al.
Publicado: (2013)

Antidementia drug use in Japan: Bridging the research‐to‐practice gap
por: Okumura, Yasuyuki, et al.
Publicado: (2018)

The situation of elderly with cognitive impairment living at home during lockdown in the Corona-pandemic in Germany
por: Thyrian, Jochen René, et al.
Publicado: (2020)

Knowledge evaluation in dementia care networks: a mixed-methods analysis of knowledge evaluation strategies and the success of informing family caregivers about dementia support services
por: Heinrich, Steffen, et al.
Publicado: (2016)

Association between antidementia medication use and mortality in people diagnosed with dementia with Lewy bodies in the UK: A retrospective cohort study
por: Chen, Shanquan, et al.
Publicado: (2022)

Relationship between antidementia medication and fracture prevention in patients with Alzheimer’s dementia using a nationwide health insurance claims database
por: Hosoi, Tatsuya, et al.
Publicado: (2023)

Implementing a physical activity project for people with dementia in Germany–Identification of barriers and facilitator using consolidated framework for implementation research (CFIR): A qualitative study
por: Cardona, Maria Isabel, et al.
Publicado: (2023)

Supporting elderly people with cognitive impairment during and after hospital stays with intersectoral care management: study protocol for a randomized controlled trial
por: Nikelski, Angela, et al.
Publicado: (2019)

Elicitation of quantitative, choice-based preferences for Person-Centered Care among People living with Dementia in comparison to physicians’ judgements in Germany: study protocol for the mixed-methods PreDemCare-study
por: Mohr, Wiebke, et al.
Publicado: (2022)

Differences and commonalities of home-based care arrangements for persons living with dementia in Germany – a theory-driven development of types using multiple correspondence analysis and hierarchical cluster analysis
por: Dreyer, Jan, et al.
Publicado: (2022)

Effectiveness of a digitally supported care management programme to reduce unmet needs of family caregivers of people with dementia: study protocol for a cluster randomised controlled trial (GAIN)
por: Klein, Olga A., et al.
Publicado: (2021)

Correction to: Effectiveness of a digitally supported care management programme to reduce unmet needs of family caregivers of people with dementia: study protocol for a cluster randomised controlled trial (GAIN)
por: Klein, Olga A., et al.
Publicado: (2021)

How is migration background considered in the treatment and care of people? A comparison of national dementia care guidelines in Europe
por: Schmachtenberg, Tim, et al.
Publicado: (2020)

Are antidementia drugs associated with reduced mortality after a hospital emergency admission in the population with dementia aged 65 years and older?
por: Hapca, Simona, et al.
Publicado: (2019)

Structures for the care of people with dementia: a European comparison
por: Schmachtenberg, Tim, et al.
Publicado: (2022)

Burden of caring for people with dementia – comparing family caregivers and professional caregivers. A descriptive study
por: Seidel, Désirée, et al.
Publicado: (2019)

Comparing national dementia plans and strategies in Europe – is there a focus of care for people with dementia from a migration background?
por: Schmachtenberg, Tim, et al.
Publicado: (2020)

Association Between Hearing and Vision Impairment and Risk of Dementia: Results of a Case-Control Study Based on Secondary Data
por: Michalowsky, Bernhard, et al.
Publicado: (2019)

Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study
por: Martinez, Carlos, et al.
Publicado: (2013)

Effect of the COVID-19 lockdown on disease recognition and utilisation of healthcare services in the older population in Germany: a cross-sectional study
por: Michalowsky, Bernhard, et al.
Publicado: (2020)

Isolation, Identification and Characterization of a Antidementia Acetylcholinesterase Inhibitor-Producing Yarrowia lipolytica S-3
por: Kang, Min-Gu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tlmn1ca4dvkpug826drhm77qpr